BioCryst Reports Fourth Quarter and Full Year 2024 Financial Results and Upcoming Key Milestones
ORLADEYO net revenue of $124.2 million for Q4 2024 (+36.6 percent y-o-y) and $437.7 million for FY 2024 (+34.3 percent y-o-y)——FY 2025 ORLADEYO ...
Medscape30m
ALS Trials Fail to Meet Key Endpoints…But It’s Still a Win and Here’s Why
While main results from a platform study of four experimental drugs for amyotrophic lateral sclerosis are negative, it shows ...
HotCopper.com on MSN6h
Actinogen reports busy 6 months as development of Xanamem molecule ramps up
Actinogen Medical Ltd (ASX:ACW) said its net loss after tax for the six months to December 2024 decreased by 29% to ...
University of Hawaii Cancer Center and Queen’s to collaborate on oncology clinic
COURTESY UH CANCER CENTER The Queen’s Health Systems and University of Hawaii Cancer Center will develop an oncology clinic at the UH John A. Burns School of Medicine in Kakaako. 1 /3 COURTESY UH ...